Skip to main content

Table 4 Various laboratory data before and after operation between the two studied groups

From: Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patients

 

Study group (N = 44)

Control group (N = 41)

Difference 1,2 [95% C.I.]

P

FFA (mmol/L)

    

 Day -1

0.60 ± 0.35

0.65 ± 0.41

-0.044 [-0.196; 0.108]

0.566

 Day 7 – Day -1

-0.20 ± 0.38

-0.03 ± 0.62

-0.195 [-0.347; -0.042]

0.013

TG (mg/dL)

    

 Day -1

97.45 ± 41.12

95.06 ± 38.72

2.263 [-13.714; 18.239]

0.779

 Day 7 – Day -1

20.98 ± 44.85

66.69 ± 68.85

-44.109 [-68.583; -19.634]

<0.001

Cholesterol (mg/mL)

    

 Day -1

179.22 ± 34.27

177.77 ± 39.04

1.188 [-13.225; 15.600]

0.870

 Day 7 – Day -1

-42.61 ± 32.00

-40.71 ± 34.86

-2.001 [-13.549; 9.546]

0.731

LDL (mg/mL)

    

 Day -1

110.99 ± 23.93

109.40 ± 36.00

1.660 [-10.504; 13.823]

0.787

 Day 7 – Day -1

-28.70 ± 25.76

-27.41 ± 30.50

-1.350 [-11.281; 8.581]

0.788

HDL (mg/mL)

    

 Day -1

37.85 ± 12.62

40.57 ± 14.87

-2.889 [-8.031; 2.254]

0.268

 Day 7 – Day -1

-12.58 ± 8.70

-17.36 ± 10.01

3.226 [0.796; 5.656]

0.010

Insulin (mU/L)

    

 Day -1

14.14 ± 14.96

21.80 ± 26.50

-7.547 [-16.107; 1.013]

0.083

 Day 7 – Day -1

22.44 ± 24.68

9.80 ± 29.44

8.080 [-1.870; 18.029]

0.110

Glucose (mg/dL)

    

 Day -1

133.31 ± 57.80

128.92 ± 52.68

4.840 [-16.791; 26.472]

0.658

 Day 7 – Day -1

20.00 ± 47.80

29.91 ± 76.32

-6.656 [-30.295; 16.983]

0.577

ALT (U/L)

    

 Day -1

18.65 ± 7.65

18.73 ± 12.16

-0.010 [-3.976; 3.956]

0.996

 Day 7 – Day -1

25.35 ± 33.30

38.48 ± 43.24

-11.141 [-26.835; 4.552]

0.162

AST (U/L)

    

 Day -1

23.77 ± 11.75

23.46 ± 11.80

0.325 [-4.394; 5.044]

0.892

 Day 7 – Day -1

18.22 ± 34.51

24.62 ± 34.26

-4.523 [-18.384; 9.337]

0.518

γGT (U/L)

    

 Day -1

21.88 ± 18.64

28.10 ± 47.67

-5.943 [-20.257; 8.371]

0.412

 Day 7 – Day -1

78.27 ± 71.93

118.24 ± 112.41

-36.052 [-73.770; 1.667]

0.061

Albumin (g/dL)

    

 Day -1

3.98 ± 0.47

4.01 ± 0.46

-0.035 [-0.194; 0.124]

0.662

 Day 7 – Day -1

-0.42 ± 0.38

-0.51 ± 0.39

0.099 [-0.038; 0.236]

0.153

Bilirubin (mg/dL)

    

 Day -1

0.15 ± 0.10

0.15 ± 0.08

0.002 [-0.034; 0.037]

0.929

 Day 7 – Day -1

0.04 ± 0.26

0.09 ± 0.33

-0.052 [-0.171; 0.067]

0.389

Leukocyte (103/μL)

    

 Day -1

5.91 ± 2.52

8.00 ± 12.85

-2.121 [-5.764; 1.522]

0.251

 Day 7 – Day -1

28.41 ± 174.51

0.67 ± 14.01

23.872 [-31.335; 79.079]

0.392

  1. FFA: free fatty acid; TG: triglyceride; LDL: low density lipoprotein; HDL: high density lipoprotein; ALT: alanine aminotransferase; AST: aspartate aminotransferase; γGT; gamma-glutamyl transpeptidase.
  2. 1Difference = [study group] - [control group].
  3. 2ANOVA incorporating center effect and their respective baseline as covariate; Difference and 95% C.I. was based on the LS-mean.